This guidance is being distributed to all treating physicians worldwide except those in the European Union (EU). Separate guidance will

We would like to take this opportunity to provide an important update to the Pompe Community. Background In the early

We would like to take this opportunity to provide an important update to the global Pompe Community. Background In the

The US Food and Drug Administration (FDA) has informed Genzyme that the FDA plans an accelerated approval for alglucosidase alfa

The US Food and Drug Administration (FDA) held a meeting of its Endocrinologic and Metabolic Drugs Advisory Committee on October